Next stage in genetic research brings us closer to understanding epilepsy
More than 800 DNA samples from Epilepsy Society have now been sequenced as part of Genomics England's landmark 100,000 Genomes Project. This means our researchers, bioinformaticians and clinicians are at the exciting stage of being able to analyse the new data, bringing hope of groundbreaking results in the diagnosis, treatment and understanding of epilepsy.
Specialist doctors can now prescribe medicinal cannabis for epilepsy
As of this morning (1 November), specialist doctors in the UK can now prescribe cannabis-based medicines to patients with a limited number of conditions. This includes children with severe epilepsy syndromes.
How a pioneering software system is transforming brain surgery
A pioneering new approach being trialled at University College London Hospital (UCLH) hopes to make epilepsy surgery safer and easier. A team of researchers, clinicians and engineers from Epilepsy Society, UCLH, UCL and King’s College London have developed a world-leading software system called EpiNav, which stands for epilepsy navigation, and their work is being featured on today’s episode (10 October 2018) of the BBC’s Trust Me I’m a Doctor.
Review into sodium valproate - your chance to have your say
An independent safety review into the epilepsy medication, sodium valproate, is now officially open and has put out a 'call for evidence' from those affected by the drug.
Teva UK discontinues lamotrigine tablets
Teva UK have announced that they are discontinuing the following versions of Teva lamotrigine, although some will still be available for a limited period next year, as shown below:
Epilepsy Society-based neuropsychologist Sallie Baxendale wins international award
Neuropsychologist Sallie Baxendale, based at Epilepsy Society, has scooped a prestigious international award for the significant difference she has made to the treatment and care of people with epilepsy.